FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096215047> ?p ?o ?g. }

• W2096215047 endingPage "1713" @default.
• W2096215047 startingPage "1708" @default.
• W2096215047 abstract "The ESC NSTEMI and STEMI guidelines1,2 and an ACCF/ACG/AHA consensus document3 recommend treatment with proton pump inhibitors (PPIs) in patients treated with dual antiplatelet treatment (DAPT) during the initial phase of an acute coronary syndrome (ACS) (ESC Class 1A recommendation), particularly in patients with a history of GI bleeding or peptic ulcer. Several studies have raised concerns that many PPIs, especially omeprazole, might diminish the antiplatelet effects of clopidogrel, most likely through inhibition of CYP2C19 and, consequently, the conversion of clopidogrel into its active metabolite.4,5The aim of this position paper is to review the pharmacokinetic background of the interactions between these drugs, and their consequences on clinical outcomes, and to present suggestions for management of this important issue.Several agents widely used in patients on acetylsalicylic acid (ASA) may interact with the antiplatelet effects of ASA, but none through the CYP2C9 pathway by which ASA is metabolized. Recently, it has been reported that concomitant use of PPIs reduces the protective efficacy of ASA in patients with ischaemic heart disease.6,7 A case–control study investigated the antiplatelet effect of ASA in 418 ASA-treated CVD patients, 54 of whom were also treated with PPIs.7 Patients receiving PPIs had reduced antiplatelet effect of ASA, as shown by greater residual platelet aggregation responses. However, interaction between PPI and ASA is controversial.8 Potential clinical implications of these findings were explored by a registry study in a large population of ASA-treated patients with first time myocardial infarction.6 Even after adjusting for baseline variables with multivariate analysis and propensity score matching, PPI use was still significantly associated with ∼50% more ischaemic cardiovascular events. A sensitivity analysis showed no increase in risk related to the use of H2 receptor blockers.6Suggested explanations for the …" @default.
• W2096215047 created "2016-06-24" @default.
• W2096215047 creator A5005962160 @default.
• W2096215047 creator A5009996527 @default.
• W2096215047 creator A5013553039 @default.
• W2096215047 creator A5028979797 @default.
• W2096215047 creator A5033831989 @default.
• W2096215047 creator A5038405190 @default.
• W2096215047 creator A5039450208 @default.
• W2096215047 creator A5061992582 @default.
• W2096215047 creator A5065978967 @default.
• W2096215047 creator A5066832095 @default.
• W2096215047 creator A5070692790 @default.
• W2096215047 creator A5076961983 @default.
• W2096215047 creator A5077862111 @default.
• W2096215047 creator A5085204166 @default.
• W2096215047 creator A5086743821 @default.
• W2096215047 creator A5091851552 @default.
• W2096215047 date "2013-02-20" @default.
• W2096215047 modified "2023-10-01" @default.
• W2096215047 title "Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy" @default.
• W2096215047 cites W1507268483 @default.
• W2096215047 cites W1521001171 @default.
• W2096215047 cites W1587492601 @default.
• W2096215047 cites W1613006575 @default.
• W2096215047 cites W175512219 @default.
• W2096215047 cites W1924733673 @default.
• W2096215047 cites W1969182570 @default.
• W2096215047 cites W1985354955 @default.
• W2096215047 cites W1989637487 @default.
• W2096215047 cites W1990098142 @default.
• W2096215047 cites W1997854923 @default.
• W2096215047 cites W2002625639 @default.
• W2096215047 cites W2012268722 @default.
• W2096215047 cites W2026552441 @default.
• W2096215047 cites W2026997625 @default.
• W2096215047 cites W2030365404 @default.
• W2096215047 cites W2032247889 @default.
• W2096215047 cites W2037681348 @default.
• W2096215047 cites W2050500985 @default.
• W2096215047 cites W2069255298 @default.
• W2096215047 cites W2076063151 @default.
• W2096215047 cites W2076472818 @default.
• W2096215047 cites W2082741431 @default.
• W2096215047 cites W2091687606 @default.
• W2096215047 cites W2093265279 @default.
• W2096215047 cites W2097854437 @default.
• W2096215047 cites W2102393690 @default.
• W2096215047 cites W2103263328 @default.
• W2096215047 cites W2103481781 @default.
• W2096215047 cites W2106507695 @default.
• W2096215047 cites W2107933782 @default.
• W2096215047 cites W2109577952 @default.
• W2096215047 cites W2115787552 @default.
• W2096215047 cites W2118092611 @default.
• W2096215047 cites W2136489990 @default.
• W2096215047 cites W2143742417 @default.
• W2096215047 cites W2143777566 @default.
• W2096215047 cites W2144766297 @default.
• W2096215047 cites W2145425156 @default.
• W2096215047 cites W2149388786 @default.
• W2096215047 cites W2152376036 @default.
• W2096215047 cites W2162508946 @default.
• W2096215047 cites W2166950143 @default.
• W2096215047 cites W2218756993 @default.
• W2096215047 cites W2608052100 @default.
• W2096215047 cites W2883081813 @default.
• W2096215047 cites W300595399 @default.
• W2096215047 cites W3030817736 @default.
• W2096215047 doi "https://doi.org/10.1093/eurheartj/eht042" @default.
• W2096215047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23425521" @default.
• W2096215047 hasPublicationYear "2013" @default.
• W2096215047 type Work @default.
• W2096215047 sameAs 2096215047 @default.
• W2096215047 citedByCount "151" @default.
• W2096215047 countsByYear W20962150472013 @default.
• W2096215047 countsByYear W20962150472014 @default.
• W2096215047 countsByYear W20962150472015 @default.
• W2096215047 countsByYear W20962150472016 @default.
• W2096215047 countsByYear W20962150472017 @default.
• W2096215047 countsByYear W20962150472018 @default.
• W2096215047 countsByYear W20962150472019 @default.
• W2096215047 countsByYear W20962150472020 @default.
• W2096215047 countsByYear W20962150472021 @default.
• W2096215047 countsByYear W20962150472022 @default.
• W2096215047 countsByYear W20962150472023 @default.
• W2096215047 crossrefType "journal-article" @default.
• W2096215047 hasAuthorship W2096215047A5005962160 @default.
• W2096215047 hasAuthorship W2096215047A5009996527 @default.
• W2096215047 hasAuthorship W2096215047A5013553039 @default.
• W2096215047 hasAuthorship W2096215047A5028979797 @default.
• W2096215047 hasAuthorship W2096215047A5033831989 @default.
• W2096215047 hasAuthorship W2096215047A5038405190 @default.
• W2096215047 hasAuthorship W2096215047A5039450208 @default.
• W2096215047 hasAuthorship W2096215047A5061992582 @default.
• W2096215047 hasAuthorship W2096215047A5065978967 @default.
• W2096215047 hasAuthorship W2096215047A5066832095 @default.
• W2096215047 hasAuthorship W2096215047A5070692790 @default.

• next